Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

• Status: Completed
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if a new treatment is effective for the treatment of recurrent symptomatic oral herpes virus infections.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beech Tree Labs, Inc.
• Collaborator: Norwich Clinical Research Associates Ltd.

Criteria

Inclusion Criteria:

• Clinical history of recurrent cold sores averaging 2 or more episodes per year

• Experiences prodromal symptoms (tingling, burning, itching) of cold sores

• Herpes Simplex Virus seropositive (by blood test)

Exclusion Criteria:

• Immuno-suppressed or taking immunosuppressant medication

• Use of antiviral therapy directly prior and during the study